MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$288,101K
Short-term marketable
securities
$106,565K
Receivables from
collaborative arrangements
$15,584K
Other prepaid and
current assets
$7,384K
Total current assets
$417,634K
Other assets
$25,303K
Operating lease assets
$23,001K
Property and equipment,
net
$5,539K
Restricted cash
$836K
Total assets
$472,313K
Total liabilities and
shareholders' equity
$472,313K
Total shareholders'
equity
$290,594K
Unrecognized tax benefits
$87,153K
Future royalty payment
contingency
$32,795K
Total current
liabilities
$31,775K
Long-term operating lease
liabilities
$29,752K
Other long-term
liabilities
$244K
Accumulated deficit
-$864,560K
Accumulated other
comprehensive income
-$62K
Additional paid-in capital
$1,155,215K
Operating lease
liabilities
$10,752K
Accrued
personnel-related expenses
$8,730K
Income tax payable
$5,287K
Accrued general and
administrative expenses
$2,522K
Accrued clinical and
development expenses
$2,396K
Accounts payable
$1,100K
Other accrued
liabilities
$988K
Ordinary shares, 0.00001
par value per share...
$1K
Back
Back
Balance Sheet
Theravance Biopharma, Inc. (TBPH)
Theravance Biopharma, Inc. (TBPH)
source: myfinsight.com